NIAID Emerging and Re-emerging Infectious Diseases NIAID Bioinformatics Resource Centers NIAID Structural Genomic Centers Center for Structural Genomics of Infectious Disease
Seattle Structural Genomics Center for Infectious Disease

MyavA.01124.a: Daunorubicin resistance ATP-binding protein DrrA

Target Characteristics

from organism: Mycobacterium avium 104
most recent status: soluble
center reference id: MyavA.01124.a
is community request: False
associated disease: Johne's disease, paratuberculosis
NIH risk group: 2
is select agent: False
NIH priority
pathogens category:
IIIC

Ordering Clones & Proteins

If there are materials available for this target, they will be listed below. Materials can be ordered from SSGCID using the button in the "order material" column. Clicking the button will add the material to a virtual cart. You may order multiple materials at a time at no cost to you, as this contract is funded by NIAID. When you are ready to place your order, click the "Place Order" link which will appear in the top right corner of the page after you place your first item in your cart.

Clones*

CENTER
REFERENCE ID
DOMAIN/REGION
DESCRIPTION
INFO AA
START
AA
STOP
ORDER
MATERIAL
MyavA.01124.a.A1.GE29064 Full length( MyavA.01124.a ) 1 315 GE29064
* SSGCID clones represent un-induced expression constructs which have been verified by sequencing from vector primers. Clones may contain a tag, such as N-term 6xHis. Get sequence information using the button in the "info" column.

External Resources

Resource Reference ID
OrthoMCL: OG5_126568
PATRIC ID: fig|243243.7.peg.3182
RefSeq: YP_882432.1
UniProt: A0A0H3A130

Sequences

These sequences are the native gene sequence; sequences of constructs derived from these sequences may differ due to codon optimization or other protocols. To find the specific sequence of any material you may have ordered, click on the "more" button next to the name of that material.
AA Sequence
MSAPAIEVEG LTKKFGGSTL ALAGVDFSVP AGTVCGLLGH NGAGKTTTIN ILSTLIRPTS GRARVAGYDV VRQPAEVRAS IGMAGQFTGM DPMLTGRENL VLFGRLRGLN RRRAKARADE LLEQFNLVDA ADRRLSTYSG GMYRRVDLAS ALVVPPKVLF LDEPTTGLDP RSRRDVWALV SSLRVQGISV LLTTQYLEEA DVLSDSIVVI DHGRVIASGT SEELKRAVGT SYCQVTPANP AELPQVAAAL TGLEGIEIDS DTGSVSVFAP DGVATLVEVF RRVDALGLEL ADISLRKPSL DEAFLHLTER TVARS

NT Sequence
GTGAGCGCAC CGGCGATCGA GGTCGAAGGC CTCACAAAGA AATTCGGGGG GAGCACGCTC GCACTGGCCG GGGTGGACTT CTCGGTTCCG GCCGGGACGG TGTGCGGGCT GCTCGGCCAC AACGGCGCGG GCAAAACCAC TACGATCAAC ATCTTGTCCA CGCTGATCCG CCCGACGTCG GGCCGGGCCC GTGTCGCCGG GTATGACGTC GTTCGCCAGC CGGCCGAGGT ACGCGCCAGC ATCGGGATGG CCGGGCAGTT CACCGGAATG GACCCCATGC TGACGGGCCG GGAGAACCTG GTGTTGTTCG GCAGGCTGCG GGGACTCAAT CGGCGGCGGG CGAAGGCCCG CGCCGACGAA CTGCTCGAAC AGTTCAACCT GGTCGACGCC GCCGACCGGC GGCTGTCGAC CTACTCCGGG GGCATGTACC GCCGCGTCGA TCTGGCCAGC GCACTGGTGG TGCCGCCGAA GGTGCTCTTC CTCGACGAGC CGACCACCGG GCTGGATCCG CGCAGCCGCC GCGACGTGTG GGCCCTGGTG AGTTCGCTGC GGGTGCAGGG CATCTCCGTG CTGCTGACCA CGCAGTACCT GGAAGAGGCC GACGTGCTGA GCGACTCGAT CGTCGTCATC GATCACGGGC GGGTGATCGC CAGCGGCACG TCCGAGGAGC TCAAGCGGGC GGTGGGGACC AGCTACTGCC AGGTGACCCC GGCCAACCCC GCCGAACTTC CCCAGGTAGC GGCCGCGCTA ACAGGGCTCG AAGGGATCGA GATCGACAGC GACACCGGCT CGGTGTCGGT GTTCGCCCCC GACGGGGTGG CCACCCTGGT CGAGGTGTTC CGCCGCGTGG ACGCGCTGGG GCTCGAGCTC GCCGACATCT CGCTGCGCAA GCCGTCGCTG GACGAAGCGT TCCTGCACCT GACCGAACGG ACCGTCGCCC GGTCA

© 2022 Seattle Children's Research Institute. All rights reserved.